Method for the production of diarylcycloalkyl derivatives

Details for Australian Patent Application No. 2005276642 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Zocher, Frank; Stuedemann, Thomas; Tappertzhofen, Christoph; Kulitzscher, Berndt; Hoerlein, Rolf; Salagnad, Christophe; Maier, Claus-Jurgen; Mutti, Stephane; Junker, Bernd; Hachtel, Jochen; Holla, Wolfgang; Burgard, Andreas

Agent Watermark

Pub. Number AU-B-2005276642

PCT Pub. Number WO2006/021420

Priority 10 2004 040 736.3 23.08.04 DE

Filing date 23 August 2005

Wipo publication date 2 March 2006

Acceptance publication date 22 December 2011

International Classifications

C12P 7/62 (2006.01) Preparation of oxygen-containing organic compounds - Carboxylic acid esters

C07C 67/03 (2006.01) Preparation of carboxylic acid esters

C07D 263/62 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 309/12 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

15 March 2007 PCT application entered the National Phase

  PCT publication WO2006/021420 Priority application(s): WO2006/021420

22 December 2011 Application Accepted

  Published as AU-B-2005276642

19 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005276648-Heterocyclic antiviral compounds

2005276640-2-sulfanyl-benzoimidazol-1-yl-acetic acid derivatives as CRTH2 antagonists